COVID statistics

According to the information announced at the meeting of the Operational Headquarters under the President for prevention of the spread of coronavirus 359 Pridnestrovians are carriers of COVID-19 at the moment. 121 of them are being treated at home, 238 in two infectious diseases hospitals, the total workload of which is 56%. Due to the deteriorating state of health in the period from 19 to 25 July, 29 carriers of the virus were transferred from home to hospital treatment. 40 people or 17% of the total number of citizens hospitalized at the moment are difficult to tolerate the coronavirus, seven are patients in intensive care units, two are connected to a ventilator. 184 Pridnestrovians are in self-isolation at home.

3856 samples of biomaterial of citizens with suspected infection were examined during the week (247993 during the entire time of the pandemic). The fact of the disease in the reporting period was confirmed in 273 cases. An increase in the average daily incidence was recorded from 27 to 39 cases. In total, 50650 cases of COVID-19 infection were recorded in Pridnestrovie during the coronavirus pandemic. 1242 carriers of the virus – 2.4% of cases – died (7 deaths during the week), 49049 people – 97% of those infected – coped with the disease (during the reporting period, 187 recovered).

41662 Pridnestrovians were vaccinated with the Sputnik V first component, 38794 people received both doses of this vaccine. 6588 people passed the first stage of vaccination with the AstraZeneca, 4436 - completed the course. 6218 residents of the republic were vaccinated with the first dose of Pfizer, 6023 - completed vaccination with this vaccine. The first dose of the Sinopharm vaccine was received by 11715 people, 8125 people received both doses of this vaccine, 7407 people underwent the first stage of vaccination with the Sinovac, and 3600 completed the course. 1946 Pridnestrovians were vaccinated with the Janssen vaccine. The republic is expected to receive 10512 doses (for vaccination of 5256 people) of Pfizer in the near future.